Pluri Inc. (PLUR)
NASDAQ·Healthcare·Biotechnology
$1.06
-3.64%
Mkt Cap $27.51M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+1032.1%
Consensus $12.00 vs current $1.06
NASDAQ·Healthcare·Biotechnology
$1.06
-3.64%
Mkt Cap $27.51M
No recent rating data.
Price Target (1 analysts)
$12.00
Range $12.00 – $12.00
+1032.1%
Consensus $12.00 vs current $1.06